These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23959318)

  • 1. Adaptation of Enterococcus faecalis to daptomycin reveals an ordered progression to resistance.
    Miller C; Kong J; Tran TT; Arias CA; Saxer G; Shamoo Y
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5373-83. PubMed ID: 23959318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic basis for in vivo daptomycin resistance in enterococci.
    Arias CA; Panesso D; McGrath DM; Qin X; Mojica MF; Miller C; Diaz L; Tran TT; Rincon S; Barbu EM; Reyes J; Roh JH; Lobos E; Sodergren E; Pasqualini R; Arap W; Quinn JP; Shamoo Y; Murray BE; Weinstock GM
    N Engl J Med; 2011 Sep; 365(10):892-900. PubMed ID: 21899450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LiaR-independent pathways to daptomycin resistance in Enterococcus faecalis reveal a multilayer defense against cell envelope antibiotics.
    Miller WR; Tran TT; Diaz L; Rios R; Khan A; Reyes J; Prater AG; Panesso D; Shamoo Y; Arias CA
    Mol Microbiol; 2019 Mar; 111(3):811-824. PubMed ID: 30582877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids.
    Tran TT; Panesso D; Mishra NN; Mileykovskaya E; Guan Z; Munita JM; Reyes J; Diaz L; Weinstock GM; Murray BE; Shamoo Y; Dowhan W; Bayer AS; Arias CA
    mBio; 2013 Jul; 4(4):. PubMed ID: 23882013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and genotype alteration during adaptive evolution of Enterococcus faecalis to antimicrobials.
    Sun Y; Lu H; Zhang X; Wu Q; Bi W; Liu H; Cao J; Zhou T
    Infect Genet Evol; 2018 Aug; 62():80-85. PubMed ID: 29625241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic basis for daptomycin resistance in enterococci.
    Palmer KL; Daniel A; Hardy C; Silverman J; Gilmore MS
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3345-56. PubMed ID: 21502617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An essential protease, FtsH, influences daptomycin resistance acquisition in Enterococcus faecalis.
    Nair ZJ; Gao IH; Firras A; Chong KKL; Hill ED; Choo PY; Colomer-Winter C; Chen Q; Manzano C; Pethe K; Kline KA
    Mol Microbiol; 2024 May; 121(5):1021-1038. PubMed ID: 38527904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of cardiolipin synthase mutations associated with daptomycin resistance in enterococci.
    Davlieva M; Zhang W; Arias CA; Shamoo Y
    Antimicrob Agents Chemother; 2013 Jan; 57(1):289-96. PubMed ID: 23114777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Level Antibiotic Tolerance of a Clinically Isolated Enterococcus faecalis Strain.
    Gu H; Roy S; Zheng X; Gao T; Ma H; Soultan Z; Fortner C; Nangia S; Ren D
    Appl Environ Microbiol; 2020 Dec; 87(1):. PubMed ID: 33097497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis.
    Reyes J; Panesso D; Tran TT; Mishra NN; Cruz MR; Munita JM; Singh KV; Yeaman MR; Murray BE; Shamoo Y; Garsin D; Bayer AS; Arias CA
    J Infect Dis; 2015 Apr; 211(8):1317-25. PubMed ID: 25362197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K; Schmidt-Malan SM; Patel R
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
    Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
    PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Mutations Commonly Associated with Daptomycin Resistance in Enterococcus faecium LiaS
    Davlieva M; Wu C; Zhou Y; Arias CA; Shamoo Y
    Biochemistry; 2018 Dec; 57(49):6797-6805. PubMed ID: 30403130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of phospholipids and glycolipids in the opportunistic pathogen Enterococcus faecalis.
    Rashid R; Cazenave-Gassiot A; Gao IH; Nair ZJ; Kumar JK; Gao L; Kline KA; Wenk MR
    PLoS One; 2017; 12(4):e0175886. PubMed ID: 28423018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Enterococcus faecium in Response to a Combination of Daptomycin and Fosfomycin Reveals Distinct and Diverse Adaptive Strategies.
    Supandy A; Mehta HH; Tran TT; Miller WR; Zhang R; Xu L; Arias CA; Shamoo Y
    Antimicrob Agents Chemother; 2022 Jun; 66(6):e0233321. PubMed ID: 35543524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Phosphodiesterase of the GdpP Family Modulates Cyclic di-AMP Levels in Response to Cell Membrane Stress in Daptomycin-Resistant Enterococci.
    Wang X; Davlieva M; Reyes J; Panesso D; Arias CA; Shamoo Y
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of resistance to daptomycin during treatment of vancomycin-resistant Enterococcus faecalis infection.
    Munoz-Price LS; Lolans K; Quinn JP
    Clin Infect Dis; 2005 Aug; 41(4):565-6. PubMed ID: 16028170
    [No Abstract]   [Full Text] [Related]  

  • 19. Rampant Parasexuality Evolves in a Hospital Pathogen during Antibiotic Selection.
    Beabout K; Hammerstrom TG; Wang TT; Bhatty M; Christie PJ; Saxer G; Shamoo Y
    Mol Biol Evol; 2015 Oct; 32(10):2585-97. PubMed ID: 26060280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.
    Prater AG; Mehta HH; Kosgei AJ; Miller WR; Tran TT; Arias CA; Shamoo Y
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.